|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 1998; 31:1658-1666 © 1998 by the American College of Cardiology Foundation |
Department of Rheumatology and Medicine, Hospital for Joint Diseases, New York University School of Medicine, New York 10003, USA. didonf01@mcrcr6.med.nyu.edu
OBJECTIVES: The present study describes the demographics, mortality, morbidity and recurrence rates of autoimmune-associated congenital heart block (CHB) using information from the Research Registry for Neonatal Lupus. BACKGROUND: Isolated CHB detected at or before birth is strongly associated with maternal autoantibodies to 48-kD SSB/La, 52-kD SSA/Ro and 60-kD SSA/Ro ribonucleoproteins and is a permanent manifestation of the neonatal lupus syndromes (NLS). Available data are limited by the rarity of the disease. RESULTS: The cohort includes 105 mothers whose sera contain anti-SSA/Ro or anti-SSB/La antibodies, or both, and their 113 infants diagnosed with CHB between 1970 and 1997 (56 boys, 57 girls). Of 87 pregnancies in which sufficient medical records were available, bradyarrhythmia confirmed to be CHB was initially detected before 30 weeks of gestation in 71 (82%) (median time 23 weeks). There were no cases in which major congenital cardiac anatomic defects were considered causal for the development of CHB; in 14 there were minor abnormalities. Twenty-two (19%) of the 113 children died, 16 (73%) within 3 months after birth. Cumulative probability of 3-year survival was 79%. Sixty-seven (63%) of 107 live-born children required pacemakers: 35 within 9 days of life, 15 within 1 year, and 17 after 1 year. Forty-nine of the mothers had subsequent pregnancies: 8 (16%) had another infant with CHB and 3 (6%) had a child with an isolated rash consistent with NLS. CONCLUSIONS: Data from this large series substantiate that autoantibody-associated CHB is not coincident with major structural abnormalities, is most often identified in the late second trimester, carries a substantial mortality in the neonatal period and frequently requires pacing. The recurrence rate of CHB is at least two- to three-fold higher than the rate for a mother with anti-SSA/Ro-SSB/La antibodies who never had an affected child, supporting close echocardiographic monitoring in all subsequent pregnancies, with heightened surveillance between 18 and 24 weeks of gestation.
This article has been cited by other articles:
|
|
 |
|
  J. Frankovich, C. Sandborg, P. Barnes, S. Hintz, and E. Chakravarty Neonatal Lupus and Related Autoimmune Disorders of Infants NeoReviews, May 1, 2008; 9(5): e206 - e217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J P Buyon, A Brucato, and D M Friedman What's in a name? Ann Rheum Dis, May 1, 2008; 67(5): 732 - 732. [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Zuppa, A. Fracchiolla, F. Cota, F. Gallini, I. Savarese, V. D'Andrea, R. Luciano, and C. Romagnoli Infants Born to Mothers With Anti-SSA/Ro Autoantibodies: Neonatal Outcome and Follow-up Clinical Pediatrics, April 1, 2008; 47(3): 231 - 236. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Skog, M. Wahren-Herlenius, B. Sundstrom, K. Bremme, and S.-E. Sonesson Outcome and Growth of Infants Fetally Exposed to Heart Block-Associated Maternal Anti-Ro52/SSA Autoantibodies Pediatrics, April 1, 2008; 121(4): e803 - e809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.P. Buyon and R.M. Clancy Dying right to live longer: positing apoptosis as a link between maternal autoantibodies and congenital heart block Lupus, February 1, 2008; 17(2): 86 - 90. [Abstract] [PDF]
|
|
|
|
|
|
G Bertsias, J P A Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, J Font, I M Gilboe, F Houssiau, T Huizinga, et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics Ann Rheum Dis, February 1, 2008; 67(2): 195 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Friedman, M. Y. Kim, J. A. Copel, C. Davis, C. K.L. Phoon, J. S. Glickstein, J. P. Buyon, and for the PRIDE Investigators Utility of Cardiac Monitoring in Fetuses at Risk for Congenital Heart Block: The PR Interval and Dexamethasone Evaluation (PRIDE) Prospective Study Circulation, January 29, 2008; 117(4): 485 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.A. Gordon Review: Congenital heart block: clinical features and therapeutic approaches Lupus, August 1, 2007; 16(8): 642 - 646. [Abstract] [PDF]
|
|
|
|
 |
|
 A. G. Tzioufas and H. M. Moutsopoulos Predicting autoimmune congenital heart block: is it feasible and how? Rheumatology, August 1, 2007; 46(8): 1221 - 1222. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Vukomanovic, M. Stajevic, J. Kosutic, P. Stojanov, S. Rakic, M. Velinovic, I. Sehic, and V. Milovanovic Age-related role of ambulatory electrocardiographic monitoring in risk stratification of patients with complete congenital atrioventricular block Europace, February 1, 2007; 9(2): 88 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Dhar and R. J. Sokol Lupus and Pregnancy: Complex Yet Manageable Clin. Med. Res., December 1, 2006; 4(4): 310 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Tincani, E Danieli, M Nuzzo, M Scarsi, M Motta, R Cimaz, A Lojacono, R Nacinovich, F Taddei, A Doria, et al. Impact of in utero environment on the offspring of lupus patients Lupus, November 1, 2006; 15(11): 801 - 807. [Abstract] [PDF]
|
|
|
|
|
|
A Parke Drug exposure, pregnancy outcome and fetal and childhood development occurring in the offspring of mothers with systemic lupus erythematosus and other chronic autoimmune diseases Lupus, November 1, 2006; 15(11): 808 - 813. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Villain, N. Coastedoat-Chalumeau, E. Marijon, Y. Boudjemline, J.-C. Piette, and D. Bonnet Presentation and Prognosis of Complete Atrioventricular Block in Childhood, According to Maternal Antibody Status J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1682 - 1687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tincani, C. B. Rebaioli, M. Taglietti, and Y. Shoenfeld Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus Rheumatology, October 1, 2006; 45(suppl_4): iv8 - iv13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Bachmann, H. Bartsch, J. K. Gross, S. M. Maier, T. F. Gross, J. L. Workman, J. A. James, A. D. Farris, B. Jung, C. Franke, et al. Autoimmunity as a Result of Escape from RNA Surveillance J. Immunol., August 1, 2006; 177(3): 1698 - 1707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L Strandberg, S Salomonsson, K Bremme, S-E Sonesson, and M Wahren-Herlenius Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies Lupus, June 1, 2006; 15(6): 346 - 353. [Abstract] [PDF]
|
|
|
|
|
|
A Tincani, D Bompane, E Danieli, and A Doria Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome) Lupus, March 1, 2006; 15(3): 156 - 160. [Abstract] [PDF]
|
|
|
|
|
|
N Costedoat-Chalumeau, S Georgin-Lavialle, Z Amoura, and J-C Piette Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block Lupus, September 1, 2005; 14(9): 660 - 664. [Abstract] [PDF]
|
|
|
|
 |
|
 Y Maeno, W Himeno, A Saito, S Hiraishi, O Hirose, M Ikuma, N Inamura, M Kawataki, A Mizukami, M Ota, et al. Clinical course of fetal congenital atrioventricular block in the Japanese population: a multicentre experience Heart, August 1, 2005; 91(8): 1075 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Qu, G. Baroudi, Y. Yue, and M. Boutjdir Novel Molecular Mechanism Involving {alpha}1D (Cav1.3) L-Type Calcium Channel in Autoimmune-Associated Sinus Bradycardia Circulation, June 14, 2005; 111(23): 3034 - 3041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. T. Jaeggi, J.-C. Fouron, E. D. Silverman, G. Ryan, J. Smallhorn, and L. K. Hornberger Transplacental Fetal Treatment Improves the Outcome of Prenatally Diagnosed Complete Atrioventricular Block Without Structural Heart Disease Circulation, September 21, 2004; 110(12): 1542 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J P Buyon, A Rupel, and R M Clancy Neonatal lupus syndromes Lupus, September 1, 2004; 13(9): 705 - 712. [Abstract] [PDF]
|
|
|
|
|
|
M Motta, A Tincani, A Lojacono, D Faden, R Gorla, P Airo, F Neri, A Gasparoni, L Ciardelli, A de Silvestri, et al. Neonatal outcome in patients with rheumatic disease Lupus, September 1, 2004; 13(9): 718 - 723. [Abstract] [PDF]
|
|
|
|
 |
|
 L. B. Holmes, D. F. Wyszynski, and E. Lieberman The AED (Antiepileptic Drug) Pregnancy Registry: A 6-Year Experience Arch Neurol, May 1, 2004; 61(5): 673 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Boldt, M. Eronen, and S. Andersson Long-Term Outcome in Fetuses With Cardiac Arrhythmias Obstet. Gynecol., December 1, 2003; 102(6): 1372 - 1379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V Fesslova, S Mannarino, P Salice, C Boschetto, L Trespidi, B Acaia, F Mosca, R Cimaz, and P L Meroni Neonatal lupus: fetal myocarditis progressing to atrioventricular block in triplets Lupus, October 1, 2003; 12(10): 775 - 778. [Abstract] [PDF]
|
|
|
|
|
|
N Costedoat-Chalumeau, Z Amoura, D Le Thi Hong, B Wechsler, D Vauthier, P Ghillani, T Papo, O Fain, L Musset, and J-C Piette Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block Ann Rheum Dis, October 1, 2003; 62(10): 1010 - 1012. [Abstract] [Full Text]
|
|
|
|
|
|
R. M. Clancy, C. B. Backer, X. Yin, R. P. Kapur, Y. Molad, and J. P. Buyon Cytokine Polymorphisms and Histologic Expression in Autopsy Studies: Contribution of TNF-{alpha} and TGF-{beta}1 to the Pathogenesis of Autoimmune-Associated Congenital Heart Block J. Immunol., September 15, 2003; 171(6): 3253 - 3261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G Solomon, A. Rupel, and J. P Buyon Letter to the Editor Lupus, August 1, 2003; 12(8): 646 - 647. [PDF]
|
|
|
|
|
|
A Brucato, A Jonzon, D Friedman, L D Allan, G Vignati, M Gasparini, J I Stein, S Montella, M Michaelsson, and J Buyon Proposal for a new definition of congenital complete atrioventricular block Lupus, June 1, 2003; 12(6): 427 - 435. [Abstract] [PDF]
|
|
|
|
 |
|
 P.J. Schwartz, A. Garson Jr, T. Paul, M. Stramba-Badiale, V.L. Vetter, E. Villain, and C. Wren Guidelines for the interpretation of the neonatal electrocardiogram Eur. Heart J., September 1, 2002; 23(17): 1329 - 1344. [Full Text] [PDF]
|
|
|
|
|
|
A D Askanase, D M Friedman, J Copel, M R Dische, A Dubin, T J Starc, M C Katholi, and J P Buyon Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies Lupus, March 1, 2002; 11(3): 145 - 151. [Abstract] [PDF]
|
|
|
|
|
|
E. T. Jaeggi, R. M. Hamilton, E. D. Silverman, S. A. Zamora, and L. K. Hornberger Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block: A single institution's experience of 30 years J. Am. Coll. Cardiol., January 2, 2002; 39(1): 130 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Buyon, D. Nugent, E. Mellins, and C. Sandborg Maternal Immunologic Diseases and Neonatal Disorders NeoReviews, January 1, 2002; 3(1): e3 - 10. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Davidson and B. Diamond Autoimmune Diseases N. Engl. J. Med., August 2, 2001; 345(5): 340 - 350. [Full Text] [PDF]
|
|
|
|
|
|
P. A. Gordon, M. A. Khamashta, G. R. V. Hughes, and E. Rosenthal A normal ECG at birth does not exclude significant congenital cardiac conduction disease associated with maternal anti-Ro antibodies Rheumatology, August 1, 2001; 40(8): 939 - 940. [Full Text] [PDF]
|
|
|
|
 |
|
 G.-Q. XIAO, Y. QU, K. HU, and M. BOUTJDIR Down-regulation of L-type calcium channel in pups born to 52 kDa SSA/Ro immunized rabbits FASEB J, July 1, 2001; 15(9): 1539 - 1545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B Maisch and A.D Ristic Immunological basis of the cardiac conduction and rhythm disorders Eur. Heart J., May 2, 2001; 22(10): 813 - 824. [PDF]
|
|
|
|
|
|
F. E. A. Udink ten Cate, J. M. P. J. Breur, M. I. Cohen, N. Boramanand, L. Kapusta, J. E. Crosson, J. I. Brenner, L. J. Lubbers, A. H. Friedman, V. L. Vetter, et al. Dilated cardiomyopathy in isolated congenital complete atrioventricular block: early and long-term risk in children J. Am. Coll. Cardiol., March 15, 2001; 37(4): 1129 - 1134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C C Mok and R W S Wong Pregnancy in systemic lupus erythematosus Postgrad. Med. J., March 1, 2001; 77(905): 157 - 165. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. H. Ballinger Cutaneous Neonatal Lupus Without Heart Block: Risks for Mother, Infant, and Future Siblings AAP Grand Rounds, February 1, 2001; 5(2): 10 - 10. [Full Text] [PDF]
|
|
|
|
|
|
M.-E. Miranda-Carus, A. D. Askanase, R. M. Clancy, F. Di Donato, T.-M. Chou, M. R. Libera, E. K. L. Chan, and J. P. Buyon Anti-SSA/Ro and Anti-SSB/La Autoantibodies Bind the Surface of Apoptotic Fetal Cardiocytes and Promote Secretion of TNF-{alpha} by Macrophages J. Immunol., November 1, 2000; 165(9): 5345 - 5351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Dubin Arrhythmias in the Newborn NeoReviews, August 1, 2000; 1(8): e146 - 151. [Full Text]
|
|
|
|
|
|
M. Eronen, M.-K. Sirèn, H. Ekblad, T. Tikanoja, H. Julkunen, and T. Paavilainen Short- and Long-Term Outcome of Children With Congenital Complete Heart Block Diagnosed In Utero or as a Newborn Pediatrics, July 1, 2000; 106(1): 86 - 91. [Abstract] [Full Text]
|
|
|
|
|
|
M. E. Miranda-Carus, M. Boutjdir, C.-E Tseng, F. DiDonato, E. K. L. Chan, and J. P. Buyon Induction of Antibodies Reactive with SSA/Ro-SSB/La and Development of Congenital Heart Block in a Murine Model J. Immunol., December 1, 1998; 161(11): 5886 - 5892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Miranda, C.-E Tseng, W. Rashbaum, R. L. Ochs, C. A. Casiano, F. Di Donato, E. K. L. Chan, and J. P. Buyon Accessibility of SSA/Ro and SSB/La Antigens to Maternal Autoantibodies in Apoptotic Human Fetal Cardiac Myocytes J. Immunol., November 1, 1998; 161(9): 5061 - 5069. [Abstract] [Full Text] [PDF]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
